Dynavax Technologies Corporation (NASDAQ:DVAX) Investors Are Paying Above The Intrinsic Value

Does the January share price for Dynavax Technologies Corporation (NASDAQ:DVAX) reflect it’s really worth? Today, I will calculate the stock’s intrinsic value by projecting its future cash flows and then discounting them to today’s value. This is done using the discounted cash flows (DCF) model. It may sound complicated, but actually it is quite simple! Anyone interested in learning a bit more about intrinsic value should have a read of the Simply Wall St analysis model. Please also note that this article was written in January 2019 so be sure check out the updated calculation by following the link below.

View our latest analysis for Dynavax Technologies

What’s the value?

We are going to use a two-stage DCF model, which, as the name states, takes into account two stages of growth. The first stage is generally a higher growth period which levels off heading towards the terminal value, captured in the second ‘steady growth’ period. To start off with we need to estimate the next five years of cash flows. For this I used the consensus of the analysts covering the stock, as you can see below. The sum of these cash flows is then discounted to today’s value.

5-year cash flow forecast

2019 2020 2021 2022 2023
Levered FCF ($, Millions) $-98.00 $-57.00 $-20.00 $57.00 $114.00
Source Analyst x2 Analyst x2 Analyst x1 Analyst x1 Analyst x1
Present Value Discounted @ 13.61% $-86.26 $-44.16 $-13.64 $34.21 $60.22

Present Value of 5-year Cash Flow (PVCF)= -US$49.6m

After calculating the present value of future cash flows in the intial 5-year period we need to calculate the Terminal Value, which accounts for all the future cash flows beyond the first stage. The Gordon Growth formula is used to calculate Terminal Value at an annual growth rate equal to the 10-year government bond rate of 2.9%. We discount this to today’s value at a cost of equity of 13.6%.

Terminal Value (TV) = FCF2023 × (1 + g) ÷ (r – g) = US$114m × (1 + 2.9%) ÷ (13.6% – 2.9%) = US$1.1b

Present Value of Terminal Value (PVTV) = TV / (1 + r)5 = US$1.1b ÷ ( 1 + 13.6%)5 = US$581m

The total value, or equity value, is then the sum of the present value of the cash flows, which in this case is US$532m. To get the intrinsic value per share, we divide this by the total number of shares outstanding, or the equivalent number if this is a depositary receipt or ADR. This results in an intrinsic value of $8.48. Relative to the current share price of $10.38, the stock is fair value, maybe slightly overvalued at the time of writing.

NasdaqCM:DVAX Intrinsic Value Export January 10th 19
NasdaqCM:DVAX Intrinsic Value Export January 10th 19

The assumptions

The calculation above is very dependent on two assumptions. The first is the discount rate and the other is the cash flows. You don’t have to agree with my inputs, I recommend redoing the calculations yourself and playing with them. Because we are looking at Dynavax Technologies as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighed average cost of capital, WACC) which accounts for debt. In this calculation I’ve used 13.6%, which is based on a levered beta of 1.513. This is derived from the Bottom-Up Beta method based on comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business.

Next Steps:

Whilst important, DCF calculation shouldn’t be the only metric you look at when researching a company. What is the reason for the share price to differ from the intrinsic value? For DVAX, I’ve compiled three essential aspects you should further research:

  1. Financial Health: Does DVAX have a healthy balance sheet? Take a look at our free balance sheet analysis with six simple checks on key factors like leverage and risk.
  2. Future Earnings: How does DVAX’s growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart.
  3. Other High Quality Alternatives: Are there other high quality stocks you could be holding instead of DVAX? Explore our interactive list of high quality stocks to get an idea of what else is out there you may be missing!

PS. Simply Wall St does a DCF calculation for every US stock every 6 hours, so if you want to find the intrinsic value of any other stock just search here.

To help readers see past the short term volatility of the financial market, we aim to bring you a long-term focused research analysis purely driven by fundamental data. Note that our analysis does not factor in the latest price-sensitive company announcements.

The author is an independent contributor and at the time of publication had no position in the stocks mentioned. For errors that warrant correction please contact the editor at editorial-team@simplywallst.com.